Genmab — Juni 2019
-
God skal vi over 1300...super skal vi over 1400...:-D
-
Næh...jeg nøjes med en håndbajer..;-)
-
i guess we will see this more and more, other companies starting studies with Dara as one of the 'Standard Treatments ' https://clinicaltrials.gov/ct2/show/NCT03989414?term=daratumumab+OR+ofatumumab+OR+tisotumab+OR+Genmab+OR+arzerra+OR+duobody&lupd_s=06%2F17%2F2019&rank=2
-
1211,50..godkendt..:-)
-
Dejligt.
-
Hej Helge...du er med satdig..:-)
-
stadig
-
Øh..Jeg er på fra tidlig morgen og sen aften?
-
Jeg skriver dog ikke så meget, når jeg kun har mobil til rådighed i bilen.
-
Ok..bare ikke så mange indput:
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind